Training providers in hypertension guidelines: Cost-effectiveness evaluation of a continuing medical education program in South Carolina

American Heart Journal

Volumn 162, Issue 4, 2011, Pages

  Trogdon, Justin G ^a   Allaire, Benjamin T ^a   Egan, Brent M ^b   Lackland, Daniel T ^b   Masters, Dory ^c  

^a RTI INTERNATIONAL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c SOUTH CAROLINA DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; EVIDENCE BASED PRACTICE; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; LIFE EXTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; SIMULATION; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

EID: 80053639459     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.06.022     Document Type: Article

References (35)

1. Y. Ostchega, S. Yoon, and J. Hughes Hypertension awareness, treatment, and control-continued disparities in adults: United States, 2005-2006 NCHS Data Brief 3 2008 1 8
2. B.M. Egan, Y. Zhao, and R.N. Axon US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2010 2043 2050
3. M.A. Schuster, E.A. McGlynn, and R.H. Brook How good is the quality of health care in the United States? Milbank Quarterly 76 1998 517 563 (Pubitemid 128463044)
4. D.A. Davis, M.A. Thomson, and A.D. Oxman Changing physician performance. A systematic review of the effect of continuing medical education strategies JAMA 274 1995 700 705
5. M. Prior, M. Guerin, and K. Grimmer-Somers The effectiveness of clinical guideline implementation strategies-a synthesis of systematic review findings J Eval Clin Pract 14 2008 888 897
6. C.A. Brown, C.R. Belfield, and S.J. Field Cost effectiveness of continuing professional development in health care: a critical review of the evidence BMJ 324 2002 652 655 (Pubitemid 34234972)
7. B.M. Egan, D.T. Lackland, and P. Igho-Pemu Cardiovascular risk factor control in communities-update from the ASH Carolinas-Georgia Chapter, the hypertension initiative, and the community physicians' network J Clin Hypertens 8 2006 879 886
8. C.M. DesRoches, E.G. Campbell, and S.R. Rao Electronic health records in ambulatory care-a national survey of physicians N Engl J Med 359 2008 50 60 (Pubitemid 351931096)
9. B.T. Allaire, J.G. Trogdon, and B.M. Egan Measuring the impact of state spending on hypertension prevention and control J Clin Hypertension 2011 http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7176.2011.00469.x/abstract
10. P. Rosenbaum, and D. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
11. A.V. Chobanian, G.L. Bakris, and H.R. Black Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 2003 1206 1252 (Pubitemid 37553153)
12. K.M. Anderson, P. Odell, and P. Wilson Cardiovascular disease risk profiles Am Heart J 121 1991 293 298
13. E. Finkelstein, O. Khavjou, and J. Will Assessing the ability of cardiovascular disease risk calculators to evaluate effectiveness of trials and interventions Expert Rev. Pharmacoeconomics Outcomes Res 6 2006 417 424 (Pubitemid 44304750)
14. National Cholesterol Education Program (NCEP) Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation 106 2002 3143 3421 Retrieved June 4, 2004
15. J.A. Staessen, J.G. Wang, and L. Thijs Cardiovascular protection and blood pressure reduction: a meta-analysis Lancet 358 2001 1305 1315 (Pubitemid 33016494)
16. M. Russell, D. Huse, and S. Drowns Direct medical costs of coronary artery disease in the United States Am J Cardiol 81 1998 1110 1115 (Pubitemid 28232681)
17. J. Flack, R. Casciano, and J. Casciano Cardiovascular disease costs associated with uncontrolled hypertension Manag Care Interface 15 2002 28 36 (Pubitemid 35346088)
18. US Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
19. Red Book™ for Windows® [computer program]. Version 61135 Vol. 46 2007 Thomson PDR Montvale, NJ
20. Center for Medicare and Medicaid Services. Physician fee schedule Available at: http://www.cms.hhs.gov/pfslookup/02-PFSsearch.asp Last accessed March 24, 2008
21. Summary Data Tables. Agency for Healthcare Research and Quality Available at: http://www.meps.ahrq.gov/mepsweb/data-stats/quick-tables.jsp 2009 Last accessed March 11, 2009
22. M. Klag, P. Whelton, and B. Randall Blood pressure and end-stage renal disease in men N Engl J Med 334 1996 13 18 (Pubitemid 26012498)
23. D. Wackerly, I.I.I.W. Mendenhall, and R. Scheaffer Statistics with Applications 5th ed. 1996 Wadsworth Publishing Belmont, CA
24. D. Meltzer Accounting for future costs in medical cost-effectiveness analysis Journal of Health Economics 16 1997 33 64 (Pubitemid 27224093)
25. E. Finkelstein, O. Khavjou, and J. Will Cost-effectiveness of WISEWOMAN, a program aimed at reducing heart disease risk among low-income women J Women's Health 15 2006 379 389 (Pubitemid 43891168)
26. Generic Competition and Drug Prices. Food and Drug Administration Available at: http://www.fda.gov/cder/ogd/generic-competition.htm Last accessed July 14, 2008
27. Consumer Price Index. Bureau of Labor Statistics Available at: http://www.bls.gov/CPI/ Last accessed July 14, 2008
28. TreeAge Software [computer program] 2008 TreeAge Software Inc. Williamstown, MA
29. S.D. Grosse Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold Expert Rev Pharmacoeconomics Outcomes Res 8 2008 165 178 (Pubitemid 351959547)
30. F. Sachs, L. Svetkey, and W. Vollmer Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (Dash) diet N Engl J Med 344 2001 3 10 (Pubitemid 32064838)
31. B. De Rivas, V. Barrios, and J. Redón Effectiveness of an interventional program to improve blood pressure control in hypertensive patients at high risk for developing heart failure: HEROIC Study J Clin Hypertens. 12 2010 335 344
32. A. Brown, and A. Garber Cost effectiveness of coronary heart disease prevention strategies in adults Pharmacoeconomics 14 1998 27 48 (Pubitemid 28332696)
33. I. Hajjar, J. Kotchen, and T. Kotchen Hypertension: trends in prevalence, incidence and control Annu Rev Public Health 27 2006 465 490
34. M. Heron Deaths: Leading causes for 2004 Natl Vital Stat Rep 56 2007 1 96
35. E. Arias United States Life Tables, 2004 Natl Vital Stat Rep 56 2007 1 40